Joint meta-analysis of two diagnostic tests accounting for within and between studies dependence

2024-9-11

Common odds ratio test and interval estimation for stratified bilateral and unilateral data

2024-9-10

Flexible joint model for time-to-event and non-Gaussian longitudinal outcomes

2024-9-9

Average treatment effect on the treated, under lack of positivity

2024-9-9

Delayed kernels for longitudinal survival analysis and dynamic prediction

2024-8-30

Unsupervised Liu-type shrinkage estimators for mixture of regression models

2024-8-28

Dynamic survival analysis: Modelling the hazard function via ordinary differential equations

2024-8-20

New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models

2024-8-19

Multivariate Poisson cokriging: A geostatistical model for health count data

2024-8-14

Estimation and inference on the partial volume under the receiver operating characteristic surface

2024-8-8

Accounting for regression to the mean under the bivariate t-distribution

2024-8-8

Inference for restricted mean survival time as a function of restriction time under length-biased sampling

2024-8-7

Sample size calculation for mixture cure model with restricted mean survival time as a primary endpoint

2024-8-6

A dependent circular-linear model for multivariate biomechanical data: Ilizarov ring fixator study

2024-8-6

Measuring the individualization potential of treatment individualization rules: Application to rules built with a new parametric interaction model for parallel-group clinical trials

2024-8-6

Improving estimation efficiency of case-cohort studies with interval-censored failure time data

2024-8-6

Group lasso priors for Bayesian accelerated failure time models with left-truncated and interval-censored data

2024-7-25

Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival

2024-7-25

Cause-specific hazard Cox models with partly interval censoring – Penalized likelihood estimation using Gaussian quadrature

2024-7-25

Analyzing heterogeneity in biomarker discriminative performance through partial time-dependent receiver operating characteristic curve modeling

2024-7-25

Minimizing confounding in comparative observational studies with time-to-event outcomes: An extensive comparison of covariate balancing methods using Monte Carlo simulation

2024-7-25

Erratum to “A dose–effect network meta-analysis model with application in antidepressants using restricted cubic splines”

2024-7-23

Proportion of treatment effect explained: An overview of interpretations

2024-7-1

Point estimation of the 100<i>p</i> percent lethal dose using a novel penalised likelihood approach

2024-6-12

A robust regression model for bounded count health data

2024-6-7

Evaluating prognostic biomarkers for survival outcomes subject to informative censoring

2024-6-6

Group sequential methods based on supremum logrank statistics under proportional and nonproportional hazards

2024-6-5

Optimal designs using generalized estimating equations in cluster randomized crossover and stepped wedge trials

2024-5-30

Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures

2024-5-29

Demystifying estimands in cluster-randomised trials

2024-5-23

A structured iterative division approach for non-sparse regression models and applications in biological data analysis

2024-5-23

Goodness-of-fit tests for modified Poisson regression possibly producing fitted values exceeding one in binary outcome analysis

2024-5-23

A capture-recapture modeling framework emphasizing expert opinion in disease surveillance

2024-5-20

Testing for marginal covariate effect when the subgroup size induced by the covariate is informative

2024-5-20

Robust integration of secondary outcomes information into primary outcome analysis in the presence of missing data

2024-5-20

Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity

2024-5-8

Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs

2024-5-1

Bayesian analysis of joint quantile regression for multi-response longitudinal data with application to primary biliary cirrhosis sequential cohort study

2024-4-27

Causal rule ensemble method for estimating heterogeneous treatment effect with consideration of prognostic effects

2024-4-27

The performance of marginal structural models for estimating risk differences and relative risks using weighted univariate generalized linear models

2024-4-24

Bayesian compositional models for ordinal response

2024-4-23

A simple and robust parametric shared frailty model for recurrent events with the competing risk of death: An application to the Carvedilol Prospective Randomized Cumulative Survival trial

2024-4-16

Estimating dynamic treatment regimes for ordinal outcomes with household interference: Application in household smoking cessation

2024-4-16

The “Why” behind including “Y” in your imputation model

2024-4-16

Non-stationary Bayesian spatial model for disease mapping based on sub-regions

2024-4-9

Variable selection for latent class analysis in the presence of missing data with application to record linkage

2024-4-9

Methods for non-proportional hazards in clinical trials: A systematic review

2024-4-9

An additive-multiplicative model for longitudinal data with informative observation times

2024-4-8

A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studies

2024-4-4

Isotonic design for single-arm biomarker stratified trials

2024-4-4